Dimethyl fumarate Sandoz 240 mg Norge - norsk - Statens legemiddelverk

dimethyl fumarate sandoz 240 mg

sandoz a/s - dimetylfumarat - enterokapsel, hard - 240 mg

Dimethyl fumarate Sandoz 120 mg Norge - norsk - Statens legemiddelverk

dimethyl fumarate sandoz 120 mg

sandoz a/s - dimetylfumarat - enterokapsel, hard - 120 mg

Dimethyl fumarate Glenmark 240 mg Norge - norsk - Statens legemiddelverk

dimethyl fumarate glenmark 240 mg

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hard - 240 mg

Dimethyl fumarate Glenmark 120 mg Norge - norsk - Statens legemiddelverk

dimethyl fumarate glenmark 120 mg

glenmark arzneimittel gmbh - dimetylfumarat - enterokapsel, hard - 120 mg

Dimethyl fumarate Neuraxpharm Den europeiske union - norsk - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Tecfidera 240 mg Norge - norsk - Statens legemiddelverk

tecfidera 240 mg

2care4 aps - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 240 mg Norge - norsk - Statens legemiddelverk

tecfidera 240 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 240 mg

Tecfidera 120 mg Norge - norsk - Statens legemiddelverk

tecfidera 120 mg

orifarm as - dimetylfumarat - enterokapsel, hard - 120 mg

Dimethyl fumarate Mylan Den europeiske union - norsk - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Den europeiske union - norsk - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.